Minnesota Clinical Study Center Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Minneapolis MN United States (1993)

Organization Overview

First Clinical Trial
2007
NCT00453271
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Minnesota Clinical Study Center A Division of Associated Skin Care Specialist, PA | Minnesota Clinical Study Center - Fridley MN - 763-571-4200 | Oklahoma City VAMC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Anxiety Disorders (Phase 4)

Erythema (Phase 3)

Onychomycosis (Phase 2)

Psoriasis (Phase 3)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 8